Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Join | Sign in
Home>Resources>White Papers

  White Papers

The EU Definition of Nanomaterial – Potential Measurement Methodologie

NanoSight Limited
The ROI of Contract Research Services

Accelrys
Understanding the colloidal stability of protein therapeutics using dy

Malvern Instruments Limited
Understanding the conformational stability of protein therapeutics usi

Malvern Instruments Limited
Use of DLS/Raman to study the thermal unfolding process of lysozyme

Malvern Instruments Limited
White Paper on Promoting Integrity in Scientific Journal Publications

The council of Science Editors
<< 1 2 >>
showing results 10 to 15 of 15
Scientific News
Study Announces a Durable Vaccine for Ebola
Researchers from Plymouth University have led team which has developed a durable vaccine for Ebola together with a disseminating vaccine strategy.
New Hopes For Rheumatic Fever Vaccination
Progress is made by a new initiative funded by CANVAS.
A Vaccine Against Placental Malaria Made with ExpreS2
ExpreS2ion Biotechnologies’ protein expression technology is ready to start human tests in Germany and Benin.
Strengthening the Immune System’s Fight Against Brain Cancer
NIH-funded research suggests novel way to improve vaccine efficacy in brain tumors.
NIH-Sponsored HIV Vaccine Trial Launches In South Africa
Early-stage trial aims to build on RV144 results.
New Class of Antibodies Raises Hope of Dengue Fever Vaccine
Scientists have discovered a new class of human antibodies against the dengue fever virus, which could be exploited to develop a vaccine.
Ebola Vaccine Trial Opens in Liberia
Study led by Liberia-NIH partnership will test two experimental vaccines.
Beating The Clock: New Treatment For Rabies Developed
University of Georgia researchers have developed a new treatment for rabies.
Utilizing Fast HPLC Screening Methods for the Detection of Steroids
Analysis of steroids improved by choosing the optimal HPLC column for the separation.
New Approach May Lead to Inhalable Vaccines
The approach using nanoparticles could lead to development of inhalable vaccines for influenza, pneumonia and tuberculosis.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters